Single-arm phase II trials can provide compelling results that facilitate the approval of a new therapy. Designing and interpreting single-arm studies based on four principles — instinct, comparative analysis, statistical soundness and like-for-like comparisons — can provide indications as to which drugs are most likely to provide improved therapeutic options for patients. References 1. Tang, H. et al. Comparison of error rates in single-arm versus randomized phase II cancer clinical trials. J. Clin.